National Institute for Cancer Control introduces product supporting cancer patients
In order to help the community better understand the role of science in improving health, a group of scientists has been talking about how research led them to develop a new way which may help improve resistance to cancer.
A meeting to introduce the health protection product K1Fucoidan. (Photo: VNA)
Hanoi (VNS/VNA) - In order to help the community better understand the role of science in improving health, a group of scientists has been talking about how research led them to develop a new way which may help improve resistance to cancer.
The National Institute for Cancer Control developed a special research project into the preparation of the food supplement, Fucolen.
With positive results, supporting the treatment of cancer patients, that science has been turned into a practical application, a health protection product called K1Fucoidan.
Statistics from the National Institute for Cancer Control, show that as of 2020, the total number of cancer cases in Vietnam was 353,826, half of them were newly discovered in 2020 and the total number of deaths by that year was 122,960.
Associate Professor Dr. Tran Thi Thanh Huong of the National Institute for Cancer Control said at a recent meeting on science and health that thanks to the research project, scientists had developed a stable and safe formula in terms of volume and ingredients in one Fucoidan hard capsule.
Fucoidan contains brown algae seaweed which has the ability to inhibit the growth, proliferation, metastasis of cancer cells, eliminate excess cell toxins and eliminate inflammatory processes.
Lentinan in shiitake mushrooms provides Beta Glucan, which has a special regulatory effect on the immune system, helping to increase and maintain peak activity of T cells, increasing the activity of natural killer cells.
Fucoidan's ability to strengthen the immune system is effective when combined with shiitake mushrooms, helping to produce more natural immune cells, thereby improving the immune system and supporting the protection of benign cells, preventing external pathogens from attacking the body.
This has had a positive impact, helping patients redu🌊ce the risk of♔ complications of infectious diseases from external sources./.
K (Cancer) Hospital and AstraZeneca Vietnam signed a Memorandum of Understanding with a focus on promoting research and development and improving cancer treatment quality in Vietnam.
Clinical research plays a significant role in developing and applying new methods for diagnosing and treating cancer, which has helped extend the lives of late-stage lung cancer patients from mere months to years, said health experts.
Health Minister Dao Hong Lan and Chief Representative of the Japan International Cooperation Agency (JICA) – Vietnam Office Sugano Yuichi on May 28 signed an agreement on grant worth 300 billion VND (11.78 million USD) for a project on improving medical equipment at National Cancer Hospital in Hanoi.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
